Inventor

SEDLACEK HANS-HARALD

DE44 patents

⚠️ This page may combine multiple inventors who share the name “SEDLACEK HANS-HARALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEDLACEK HANS-HARALD

AVENTIS PHARMA GMBH

DNA for expression under control of a cell cycle-dependent promoter

Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof

Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use

Nucleic acid construct for the cell cycle regulated expression of structural genes

Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use

Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

Nucleic acid constructs containing genes encoding transport signals

Nucleic acid constructs containing hybrid promoters

Nucleic acid constructs whose activity is affected by inhibitors of cyclin-dependent kinases and uses thereof

Self-enhancing, pharmacologically controllable expression systems

Oncogene- or virus-controlled expression systems

Self-enhancing, pharmacologically controllable expression systems

Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

Complex-forming proteins

Chimeric antibody against tumor associated antigens and its use in diagnosing tumors

HOECHST AG

Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound

Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use

Use of the diterpene derivative forskolin for immunostimulation

Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use

Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs

Cell-specific gene therapy using as promoter novel promoters for tissue inhibitors of metalloproteinase-3

Promoter of the cdc25B gene, its preparation and use

Cell-specific active compounds regulated by the cell cycle

Monofunctional and bisfunctional anthraquinone-(oxy-2,3-oxidopropanes), processes for their preparation, and their use as drugs

1,3-thiazoles and their use as immunomodulators

Anthracycline derivatives and their use as cytostatics

Immunosuppressive chromone alkaloid

Immunostimulating agent

Promoter of the human endoglin gene

BEHRINGWERKE AG

Use of pairs of leucine zipper peptides in immunoassay methods

Substituted phenols and their use for the treatment of disorders caused by cell proliferation

Tanned thrombocytes

Process for immunologic determination tests

Use of Lycorine as an immunosuppressor

Method and agent for the therapy of immunocomplex diseases

Immunologic determination method

Methods for the detection of antimitochondrial and antinuclear antibodies

VECTRON THERAPEUTICS AG

Single-chain multiple antigen-binding molecule, its preparation and use

HOECHST LAB

Glycosylated prodrugs, their method of preparation and their uses

AFFITECH RES AS

Single-chain multiple antigen-binding molecule, its preparation and use

(unassigned)

Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof

DADE BEHRING MARBURG GMBH

Monoclonal antibodies with specificity for membrane-associated antigens

SANOFI AVENTIS PHARMA DEUTSCHL

Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

PLANZ OLIVER

Compositions and methods for the prophylaxis or treatment of viral diseases